ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Guest Editorial: Don Berry On Cancer Centers Publishing Comparative Survival Data

March 18, 2011

House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI

June 17, 1994

Colorectal, Lung Cancer Screening Techniques Show No Mortality Improvement, Conferences Find

December 1, 1978

DCPC Board Approves Concept for New Nutrition Grants

February 10, 1989

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992